← Back to Search
In Vivo Effects Of Antibodies To Immune Response Gene Products. II. Suppression Of Humoral Immune Responses With Monoclonal Anti-I-A Is Due To Suppressor Cells.
N. Adelman, D. Watling, H. Mcdevitt
Published 1988 · Biology, Medicine
Save to my Library
Download via 🐼 PaperPanda Download via oaDOI Download via OAB Download via LibKey Download via Google Google ScholarAnalyze on Scholarcy Visualize in Litmaps
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
The I region of the murine major histocompatibility complex (H-2) encodes two cell surface glycoprotein complexes (Aα:Aβ and Eα:Eβ) which exert profound control over many immunologic reactions including humoral and cellular responses to a variety of antigens, i.e., Ir gene effects, stimulation in mixed lymphocyte reaction, graft versus host disease, antigen presentation to T cells by macrophages, collaboration between T and B cells and determination of T cell help or suppression [1-13]. In the past few years, several laboratories have reported that antibodies directed against I region gene products (anti-la) are effective in modulating immune responses both in vitro and in vivo [14-32, 48-51]. The ability of anti-la antibodies to alter immune responsiveness was attributed to their interaction with macrophage la antigens, thus masking or sterically hindering la epitopes involved in antigen presentation [16,17, 33-35]. However, other reports have suggested that additional mechanisms may be involved [28, 36-...
This paper references
Genetic Control of the Antibody Response: Relationship between Immune Response and Histocompatibility (H-2) Type
H. Mcdevitt (1969)
GENETIC CONTROL OF THE IMMUNE RESPONSE
H. Mcdevitt (1972)
A rapid method for the isolation of functional thymus‐derived murine lymphocytes
M. H. Julius (1973)
ALLOANTISERUM-INDUCED INHIBITION OF IMMUNE RESPONSE GENE PRODUCT FUNCTION
E. Shevach (1974)
Antigen-specific T-cell factor in cell cooperation. Mapping within the I region of the H-2 complex and ability to cooperate across allogeneic barriers
M. Taussig (1975)
Genetic control of specific immune suppression. II. H-2-linked dominant genetic control of immune suppression by the random copolymer L- glutamic acid50-L-tyrosine50 (GT)
P. Debré (1975)
Inhibition of immune responses in vitro by specific antiserums to Ia antigens.
J. Frelinger (1975)
THE ROLE OF PRODUCTS OF THE HISTOCOMPATIBILITY GENE COMPLEX IN IMMUNE RESPONSES
D. Katz (1975)
Suppressor cell induction in vitro. I. Kinetics of induction of antigen‐specific suppressor cells
S. Kontiainen (1976)
T lymphocyte-enriched murine peritoneal exudate cells. III. Inhibition of antigen-induced T lymphocyte Proliferation with anti-Ia antisera.
R. Schwartz (1976)
Generation of specific helper cells and suppressor cells in vitro for the IgE and IgG antibody responses.
K. Ishizaka (1976)
Properties of the antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. IV. Special subregion assignment of the gene(s) that codes for the suppressive T-cell factor in the H-2 histocompatibility complex
T. Tada (1976)
Antigen specific T cell factors in the genetic control of the immune response to poly(tyr,glu)poly(pro)--poly(lys).
E. Mozes (1976)
A Cardinal Role for I‐Region Antigens (Ia) in Immunological Enhancement, and the Clinical Implications
D. A. Davies (1976)
Potentiation of a primary in vivo antibody response by alloantisera against gene products of the I region of the H-2 complex.
M. Pierres (1977)
Reduction of syngeneic tumor growth by an anti-I-J-alloantiserum.
M. Greene (1977)
INHIBITORY EFFECT OF ANTI-Ia SERA ON PROLIFERATIVE RESPONSES TO (H,G)-A--L and (Phe,G)-A--L
P. Lonai (1978)
Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens.
V. T. Oi (1978)
Function of macrophages in genetic control of immune responsiveness.
A. Rosenthal (1978)
Two-gene control of the expression of a murine Ia antigen
P. Jones (1978)
Structural studies on the murine Ia alloantigens. VI. Evidence that both subunits of the I-A alloantigen are encoded by the I-A subregion.
R. Cook (1979)
Structural studies on the murine Ia alloantigens. V. Evidence that the structural gene for the I-E/C beta polypeptide is encoded within the I- A subregion
R. Cook (1979)
Structural polymorphism of I–E subregion antigens determined by a gene in the H–2K to I–B genetic interval
J. Silver (1979)
Monoclonal antibody against an Ir gene product?
E. Lerner (1980)
Participation of suppressor T cells in the immunosuppressive activity of a heteroantiserum to human Ia-like antigens (p23,30)
S. Broder (1980)
Effects of blocking helper T cell induction in vivo with anti-Ia antibodies. Possible role of I-A/E hybrid molecules as restriction elements
J. Sprent (1980)
In vivo or in vitro treatments with anti-I-J alloantisera abolish immunity to AKR leukemia.
D. Meruelo (1980)
Definitive mapping of the immune response gene(s) for (T,G)-A--L to the I-A subregion.
M. Markman (1980)
Mechanisms of regulation of cell-mediated immunity: anti-I-A alloantisera interfere with induction and expression of T-cell-mediated immunity to cell-bound antigen in vivo.
L. Perry (1980)
In vivo effects of antibodies to immune response gene products. I. Haplotype-specific suppression of humoral immune responses with a monoclonal anti-I-A
J. Rosenbaum (1981)
T cell subset interactions in the regulation of syngeneic tumor immunity.
L. Perry (1981)
In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis.
L. Steinman (1981)
Modulation of Schistosoma mansoni egg-induced granuloma formation: I-J restriction of T cell-mediated suppression in a chronic parasitic infection.
W. Green (1981)
Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes.
K. Ziegler (1981)
Genetic control of the immune response to myoglobins. IV. Inhibition of determinant-specific Ir gene-controlled antigen presentation and induction of suppression by pretreatment of presenting cells with anti-Ia antibodies.
J. Berzofsky (1981)
Structure of murine Ia antigens. Two dimensional electrophoretic analyses and high pressure liquid chromatography tryptic peptide maps of products of the I-A and I-E subregions and of an associated invariant polypeptide
M. McMillan (1981)
Immune response gene function correlates with the expression of an Ia antigen. I. Preferential association of certain Ae and E alpha chains results in a quantitative deficiency in expression of an Ae:E alpha complex.
J. McNicholas (1982)
Evidence that antisera that react with products of the human HLA-DR locus may block in vitro antigen-induced proliferation by inducing suppression.
A. Muchmore (1982)
Antigen-specific human T lymphocyte clones: mechanisms of inhibition of proliferative responses by xenoantiserum to human nonpolymorphic HLA-DR antigens.
J. Lamb (1982)
Immune response gene function correlates with the expression of an Ia antigen. II. A quantitative deficiency in A(e):E(a), complex expression causes a corresponding defect in antigen-presenting cell function
L. Matis (1982)
Conversion of immunity to suppression by in vivo administration of I-A subregion-specific antibodies
L. Perry (1982)
Anti I-A antibody suppresses active encephalomyelitis: treatment model for diseases linked to IR genes
S. Sriram (1983)
Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies
N. Adelman (1983)
In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptor.
M. Waldor (1983)
Disappearance and reappearance of B cells after in vivo treatment with monoclonal anti-I-A antibodies.
M. Waldor (1984)
Ir gene expression on T cells: Effect of a monoclonal antibody directed against I region‐controlled determinants on T cells
J. Yagi (1986)
Effect of anti‐Ia treatment on the production of anti‐DNA antibody by NZB mice
D. Klinman (1986)
The effects of an anti-I-Ab antibody on murine host resistance to Listeria monocytogenes.
R. Kurlander (1987)
This paper is referenced by
CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases
E. Favoino (2016)